Tauriga Sciences Inc. Commences Major Advertising Campaign in Times Square
October 11 2021 - 08:06AM
InvestorsHub NewsWire

This Campaign is Focused on the Company’s Flagship Brand:
Tauri-Gum™
NEW YORK, NY -- October 11, 2021 -- InvestorsHub NewsWire
-- Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a New York based diversified Life
Sciences Company, today announced that it has commenced a major
Advertising Campaign in Times Square, New York
City. This Advertising Campaign is expected to commence
on October 15, 2021 and run through January 5, 2022. The
Company expects for its flagship brand Tauri-Gum™ to benefit from
substantial exposure – including, during New Year’s Eve 2021
(December 31, 2021).
The Campaign itself consists of a large digital billboard
platform, located within the following Venue: The 1500 Broadway
Spectacular, strategically positioned in the heart of the Times
Square Plaza, “The Gateway to New York.” The Venue is
located next door to the NASDAQ Marketplace.
The actual digital billboard itself is 56 feet wide by 29 feet
tall, for a total of 1,624 square feet of viewing space.
Over the course of this 83-day advertising campaign (the
“campaign”), the airtime package guarantees a minimum of Five 15
second Tauri-Gum™ advertisements per hour / airing 20 hours per
day. Over the course of the campaign, there will be a
minimum of 8,300 of the above-referenced 15 second Tauri-Gum™
advertisements.
This Advertising Campaign is Titled: “83 Days in the Big
Apple”
The Company is working diligently on the creative aspects of
this advertising campaign (the “Ad Display”). Such will
include: 1. Images of Tauri-Gum™ Product Line; 2. Brief Product
Line Description; 3. The Company’s E-Commerce Website; 4. The
Company’s Stock Trading Symbol; 5. Promo Code – TIMES15 (15%
Discount + Free Shipping).
The Company will disclose to shareholders the final creative
layout of the Ad Display once completed
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating,
diversified life sciences company, engaged in several major
business activities and initiatives. The company
manufactures and distributes several proprietary retail products
and product lines, mainly focused on the Cannabidiol (“CBD”) and
Cannabigerol (“CBG”) Edibles market segment. The main
product line, branded as Tauri-Gum™, consists of a proprietary
supplement chewing gum that is Kosher certified, Halal certified,
and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood
Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon,
Black Currant), (DELTA 8 THC Infused Tauri-Gum™ Flavor: Evergreen
Mint), (Vitamin C + Zinc Infused Tauri-Gum™ Flavor: Pear Bellini),
(Caffeine Infused Tauri-Gum™ Flavor: Cherry Lime Rickey), &
(Vitamin D3 Infused Tauri-Gum™ Flavor: Golden
Raspberry). The Company’s commercialization strategy
consists of a broad array of retail customers, distributors, and a
fast-growing E-Commerce business segment (E-Commerce
website: www.taurigum.com). Please visit our corporate
website, for additional information, as well as inquiries,
at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing
Pharmaceutical Development initiative. This relates to the
development of a proposed Pharmaceutical grade version of
Tauri-Gum™, for nausea regulation (specifically designed for the
following indication: Patients Subjected to Ongoing Chemotherapy
Treatment). On March 22, 2021, the Company announced that it had
Converted its U.S. Provisional Patent Application (filed on March
17, 2020) into a U.S. Non-Provisional Patent
Application. The Patent, filed with the U.S.P.T.O. is
Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND
METHODS OF TREATMENT”. On December 18, 2020 the Company
disclosed that it had entered into a Master Services Agreement with
CSTI to lead the Company's clinical development efforts.
The Company is headquartered in Wappingers Falls, New
York. In addition, the Company operates two full time
E-Commerce fulfillment centers: one located in Montgomery, Texas
and the other in Brooklyn, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due to known and
unknown risks and uncertainties, such as are not guarantees of
general economic and business conditions, the ability to
successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other periodic filings made from time to time with the
Securities and Exchange Commission. Such forward-looking statements
are made only as of the date of this release, and Tauriga assumes
no obligation to update forward-looking statements to reflect
subsequent events or circumstances. You should not place undue
reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From May 2023 to Jun 2023
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Jun 2022 to Jun 2023